TRIL

Trillium Therapeutics Inc.
TRIL

Overview Fund Activity
Delisted

TRIL was delisted on the 16th of November, 2021.

Back to rankings

27 hedge funds and large institutions have $54M invested in Trillium Therapeutics Inc. in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
5
Increased
10
Reduced
4
Closed
4
Calls
$122K
Puts
$96K
Net Calls
+$26K
Net Calls Change
-$59K

Top Buyers

1
PIM
1
Platinum Investment Management
Australia
$1.26M
2
SLG
2
Stanley-Laman Group
Pennsylvania
$779K
3
MCMC
3
Matrix Capital Management Company
New Hampshire
$16.2M
4
Victory Capital Management
4
Victory Capital Management
Texas
$2.09M
5
Morgan Stanley
5
Morgan Stanley
New York
$1.63M

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$300K
2
Deutsche Bank
2
Deutsche Bank
Germany
$146K
3
CAM
3
Cormorant Asset Management
Massachusetts
$4.13M
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
OAM
5
Oxford Asset Management
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Toronto Dominion Bank
26
Toronto Dominion Bank
Ontario, Canada
$1K +$356 +31 +55%
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Quebec, Canada
$466 – – –
Citadel Advisors
28
Citadel Advisors
Florida
– -$180K -24,622 Closed
OAM
29
Oxford Asset Management
United Kingdom
– -$165K -22,097 Closed
VF
30
Virtu Financial
New York
– -$144K -19,898 Closed
Barclays
31
Barclays
United Kingdom
– -$76K -10,500 Closed
1
2